Overview

Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China

Status:
Completed
Trial end date:
2018-09-14
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the pharmacokinetics of single intravenous of Amphotericin B Colloidal Dispersion(ABCD)in Chinese healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Treatments:
Amphotericin B
Liposomal amphotericin B